---
title: "WSB Hot Discussion | SANA Soars 160.6%, QUBT Plummets 43.3%"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/26540718.md"
description: "Sana Biotechnology, Inc. SANA (SANA) 24-hour price change: 160.6% (small-cap pharmaceutical stock, generally not participating) Sana Biotechnology (stock code: SANA) has recently seen a strong surge in its stock price, mainly due to breakthrough progress in its diabetes research, coupled with a dual benefit from TD Cowen raising its rating. The market generally views the company's "hardcore" strength in the field of cell engineering therapy positively, especially its innovative breakthroughs in "bottleneck" medical challenges such as hematological malignancies and diabetes. Analysts believe..."
datetime: "2025-01-09T13:53:39.000Z"
locales:
  - [en](https://longbridge.com/en/topics/26540718.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/26540718.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/26540718.md)
author: "[复利魔方3650](https://longbridge.com/en/profiles/7185361.md)"
---

# WSB Hot Discussion | SANA Soars 160.6%, QUBT Plummets 43.3%

**Sana Biotechnology, Inc. SANA (SANA) 24-hour price change: 160.6% (pharmaceutical small-cap stock, generally not participated)**

Sana Biotechnology (stock code: SANA) has recently seen a strong surge in its stock price, primarily due to breakthrough progress in its diabetes research, coupled with a dual benefit from TD Cowen raising its rating. The market is generally optimistic about the company's "hardcore" strength in the field of cell engineering therapy, especially in innovative breakthroughs for "bottleneck" medical challenges such as hematological malignancies and diabetes. Analysts believe that the stock has sufficient upward momentum, and its technical barriers and industry position provide a "moat" for long-term growth, making its future performance worth looking forward to.

**Quantum Computing, Inc. QUBT (QUBT) 24-hour price change: -43.3%**

Affected by NVIDIA CEO's statement that "commercialization of quantum computing will take another 15-30 years," the stock price of Quantum Computing (QUBT) has suffered a sharp decline. Despite the company recently completing a $100 million private placement and securing TFLN photonic chip orders, market concerns about its technological maturity continue to escalate. As a "small but beautiful" company in the quantum computing field, it occupies a place in the industry with its portable quantum computers and quantum random number generators as "hardcore" products. However, in the context of unclear prospects for technology implementation, the stock may continue to face pressure in the short term. Industry insiders remind that while the quantum computing track has broad prospects, investors need to be wary of the risks of "concept hype."

**IonQ, Inc. IONQ (IONQ) 24-hour price change: -39.0%**

Recent comments from NVIDIA's CEO about "the commercialization of quantum computing will take another 15-30 years" have doused cold water on quantum computing concept stocks. As a result, the stock price of quantum computing leader IonQ (IONQ) has experienced a sharp decline, and market sentiment has turned sharply negative. Despite the company’s recent frequent activities, including the acquisition of Qubitekk and showcasing at CES 2025 on quantum computing topics, investor concerns about technological maturity still prevail. As a "top student" in the quantum computing field, IonQ holds advanced quantum computing systems and cloud platform cooperation resources, but market expectations for its long-term development have clearly cooled. Industry insiders believe that while the quantum computing track has broad prospects, it still needs to "weather the winter" in the short term.

Stocks hotly discussed on WSB:

Data source: swaggystocks.com, the most discussed stocks in the past 24 hours.

Risk warning: Stocks hotly discussed on WSB may experience significant volatility due to retail investor enthusiasm, please pay attention to investment risks

### Related Stocks

- [SANA.US](https://longbridge.com/en/quote/SANA.US.md)

## Comments (1)

- **水沝淼㵘9527 · 2025-01-09T14:19:53.000Z · 👍 3**: The pharmaceutical sector is too volatile. Others get beaten when breaking through, get beaten when interest rates don't drop, get beaten when experiments fail, 😂